|Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer|
SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ...
New England Journal of Medicine, 2013
|Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA|
M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ...
Nature 497 (7447), 108-112, 2013
|Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA|
T Forshew, M Murtaza, C Parkinson, D Gale, DWY Tsui, F Kaper, ...
Science Translational Medicine 4 (136), 136ra68-136ra68, 2012
|A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease|
JF Peden, JC Hopewell, D Saleheen, JC Chambers, J Hager, N Soranzo, ...
Nature genetics 43 (4), 339-344, 2011
|Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer|
M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ...
Nature communications 6 (1), 1-6, 2015
|Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis|
RF Schwarz, CKY Ng, SL Cooke, S Newman, J Temple, AM Piskorz, ...
PLoS Med 12 (2), e1001789, 2015
|Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis|
JMJ Weaver, CS Ross-Innes, N Shannon, AG Lynch, T Forshew, ...
Nature genetics 46 (8), 837-843, 2014
|Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes|
CM Beaufort, JCA Helmijr, AM Piskorz, M Hoogstraat, K Ruigrok-Ritstier, ...
PloS one 9 (9), e103988, 2014
|Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height|
MB Lanktree, Y Guo, M Murtaza, JT Glessner, SD Bailey, ...
The American Journal of Human Genetics 88 (1), 6-18, 2011
|Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma|
L Gossage, M Murtaza, AF Slatter, CP Lichtenstein, A Warren, B Haynes, ...
Genes, chromosomes and cancer 53 (1), 38-51, 2014
|The burden of stroke and transient ischemic attack in Pakistan: a community-based prevalence study|
AK Kamal, A Itrat, M Murtaza, M Khan, A Rasheed, A Ali, A Akber, Z Akber, ...
BMC neurology 9 (1), 58, 2009
|The Pakistan Risk of Myocardial Infarction Study: a resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South Asia|
D Saleheen, M Zaidi, A Rasheed, U Ahmad, A Hakeem, M Murtaza, ...
European journal of epidemiology 24 (6), 329-338, 2009
|Association of the 9p21. 3 locus with risk of first-ever myocardial infarction in Pakistanis: case-control study in South Asia and updated meta-analysis of Europeans|
D Saleheen, M Alexander, A Rasheed, D Wormser, N Soranzo, ...
Arteriosclerosis, thrombosis, and vascular biology 30 (7), 1467-1473, 2010
|Evaluation of pre-analytical factors affecting plasma DNA analysis|
H Markus, T Contente-Cuomo, M Farooq, WS Liang, MJ Borad, ...
Scientific reports 8 (1), 1-10, 2018
|Classification and clinical features of headache disorders in Pakistan: a retrospective review of clinical data|
M Murtaza, M Kisat, H Daniel, AB Sonawalla
PloS one 4 (6), e5827, 2009
|Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer|
BR McDonald, T Contente-Cuomo, SJ Sammut, A Odenheimer-Bergman, ...
Science translational medicine 11 (504), eaax7392, 2019
|The genomic and immune landscapes of lethal metastatic breast cancer|
L De Mattos-Arruda, SJ Sammut, EM Ross, R Bashford-Rogers, ...
Cell reports 27 (9), 2690-2708. e10, 2019
|Genetic determinants of major blood lipids in Pakistanis compared with Europeans|
D Saleheen, N Soranzo, A Rasheed, H Scharnagl, R Gwilliam, ...
Circulation: Cardiovascular Genetics 3 (4), 348-357, 2010
|Risk factors of stroke in Pakistan: a dedicated stroke clinic experience|
F Taj, R Zahid, M Murtaza, S Ahmed, AK Kamal
Canadian journal of neurological sciences 37 (2), 252-257, 2010
|Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer|
DWY Tsui, M Murtaza, ASC Wong, OM Rueda, CG Smith, ...
EMBO molecular medicine 10 (6), e7945, 2018